Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

雷诺考特 - NMPA Drug Approval Details

Approvals/NMPA/Budesonide Nasal Spray

Approved

化学药品

Budesonide Nasal Spray

Mcneil Sweden AB🇨🇳 National Medical Products Administration

Approval Date: Sep 27, 2023
Approval ID: 8VIZSFzERGh
Company: Mcneil Sweden AB
Type: 化学药品

Approval Details

Approval Id: 8VIZSFzERGh
Approval Number: 国药准字HJ20171312
Generic Name: 布地奈德鼻喷雾剂
Generic Name En: Budesonide Nasal Spray
Trade Name: 雷诺考特
Drug Type: 化学药品
Dosage Form: 鼻用制剂
Strength: 每瓶120喷,每喷含布地奈德64μg,药液浓度为1.28mg/ml
Reg Date: 2023-09-27
Expired Date: 2028-09-26
Company Name: Mcneil Sweden AB
Production Company Name: Mcneil AB
Company Detail Path: /organization/mcneil-sweden-ab
Production Company Detail Path: /organization/mcneil-ab

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 27, 2023

Approval ID

8VIZSFzERGh

Type

化学药品

Back to NMPA Approvals